A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery

NARecruitingINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

May 19, 2021

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
MastectomyMammaplastyBreast Reconstruction
Interventions
DEVICE

REVOLVE Advanced Adipose System

The REVOLVE system is an all-in-one fat processing device that harvests, filters, actively washes, and removes strands from lipoaspirate and allows for reinjection without any additional manipulation (REVOLVE 2020).

DEVICE

LipoGrafter

The LipoGrafter system is designed to be a start-to-finish closed system with minimal processing of the lipoaspirate, minimizing the risk of contamination and fat cell damage (LipoGrafter 2020).

PROCEDURE

Viality

The Viality system uses the AuraClens solution that acts as a surfactant to bring impurities like blood, free oil, and cellular debris into solution, where they can be flushed out through suction.

Trial Locations (1)

10021

RECRUITING

New York Presbyterian - Weill Cornell Medicine, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER